Vance Wealth, Inc. Ark Genomic Revolution ETF (De Transaction History

Vance Wealth, Inc.

$261 Million
Q1 2025

A detailed history of Vance Wealth, Inc. transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Vance Wealth, Inc. holds 10,309 shares of ARKG stock, worth $213,499. This represents 0.08% of its overall portfolio holdings.

Number of Shares

10,309

Holding current value

$213,499

% of portfolio

0.08%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 14, 2025	BUY	$20.76 - $29.81 $214,014 - $307,311	10,309 New	10,309 $214,000

Others Institutions Holding ARKG

# of Institutions

278

Shares Held

20.9M

Call Options Held

4.66M

Put Options Held

3.85M

Jpmorgan Chase & CO New York, NY

3.43M
Shares

$71.1 Million
0.01% of portfolio
Goldman Sachs Group Inc New York, NY

3.29M
Shares

$68.1 Million
0.01% of portfolio
Citigroup Inc

2.56M
Shares

$53 Million
0.03% of portfolio
Morgan Stanley New York, NY

2.37M
Shares

$49 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

1.2M
Shares

$25 Million
0.0% of portfolio

View Full List

About ARK GENOMIC REVOLUTION ETF (DE

Ticker ARKG
Sector ETFs
Industry ETFs

More about ARKG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vance Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vance Wealth, Inc. with notifications on news.

Account